Orthopedic Surgery Doctors in Stillwater, MN Accepting Medicare

4 Orthopedic Surgery doctors found. Showing 1 - 4

Dr. Eric Grant Meinberg, M.D. Orthopaedic Surgery - Orthopaedic Trauma Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234    Fax: 651-275-3325

Dr. Bryan D Den Hartog, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1701 Curve Crest Blvd W Ste 104, Stillwater, MN 55082 Phone: 651-439-8807    Fax: 651-439-0232

Andrew Charles Ockuly, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1701 Curve Crest Blvd W Ste 104, Stillwater, MN 55082 Phone: 651-439-8807    Fax: 651-439-0232

Andrew Michael Schmiesing, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1701 Curve Crest Blvd W Ste 104, Stillwater, MN 55082 Phone: 651-439-8807    Fax: 651-439-0232

News Archive

Blood cholesterol levels predict risk of heart disease due to hormone therapy

A new analysis of a subgroup of participants in the Women's Health Initiative (WHI) hormone therapy clinical trials suggests that healthy, postmenopausal women whose blood cholesterol levels are normal or lower are not at increased, short-term risk for heart attack when taking hormone therapy.

Gates Foundation blog highlights work of CDC Kenya

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

A study led by researchers at the Institute for Molecular Medicine Finland FIMM and Faculty of Medicine, University of Helsinki and the Helsinki University Central Hospital Comprehensive Cancer Center, in close collaboration with researchers at Pfizer, has identified a previously unrecognized action of Pfizer's axitinib as a potent inhibitor of the dominant mutation that confers drug resistance to all well tolerated treatments in patients with certain types of leukemia.

Activating rearrangements in receptor genes are more common than previously thought

A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.

Read more Medical News

› Verified 7 days ago